Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 92.80
0.00 (0.00%)
Jul 21, 2026, 1:14 PM CST
Acer Medical Revenue
In the year 2025, Acer Medical had annual revenue of 60.05M TWD with 19.73% growth. Acer Medical had revenue of 29.93M in the half year ending December 31, 2025, with 48.68% growth.
Revenue
60.05M
Revenue Growth
+19.73%
P/S Ratio
23.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.41B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.05M | 9.90M | 19.73% |
| Dec 31, 2024 | 50.16M | 22.71M | 82.73% |
| Dec 31, 2023 | 27.45M | 14.39M | 110.17% |
| Dec 31, 2022 | 13.06M | 3.43M | 35.66% |
| Dec 31, 2021 | 9.63M | 8.61M | 849.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 17.50B |
| Arich Enterprise | 1.56B |
| Bioptik Technology Incorporation | 865.76M |
| GeneFerm Biotechnology | 663.87M |
| GenMont Biotech Incorporation | 390.95M |
| Abnova (Taiwan) | 348.71M |
| Caliway Biopharmaceuticals | 38.04M |
| TaiRx | 27.88M |
Acer Medical News
- 4 months ago - Acer Medical Quarterly report: H2 2025 - Filings
- 1 year ago - Acer Medical Quarterly report: H1 2025 - Filings